Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 3, 1997, Pages 198-202

  Borch, K ^a   Stridsberg, M ^a   Burman, P ^a   Rehfeld, J F ^a  

^a NONE

Author keywords

atrophic gastritis; carcinoid; chromogranin; endocrine cell; enterochromaffin like cell; gastrin; gastritis; hyperplasia; stomach

Indexed keywords

CHROMOGRANIN A; GASTRIN;

ADULT; AGED; ARTICLE; CARCINOID; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOCRINE CELL; FEMALE; GASTRITIS; HISTOLOGY; HUMAN; HYPERPLASIA; MALE; NEOPLASM; PRIORITY JOURNAL; STOMACH BIOPSY;

EID: 0031043307     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709000194     Document Type: Article

References (29)

1. Solcia E, Capella C, Buffa R, Osellini L, Fiocca R, Frigerio B, et al. The diffuse endocrine-paracrine system of the gut in health and disease: ultrastructural features. Scand J Gastroenterol 1981;16 Suppl 70:25-36.
2. Arnold R, Hülst MV, Neuhof CH, Schwarting H, Becker HD, Creutzfeldt W. Antral gastrin-producing G-cells and somatos-tatin-producing D-cells in different states of gastric acid secretion. Gut 1982;23:285-91.
3. Håkanson R, Axelson J, Ekman R, Sundler F. Hypergastrinemia evoked by omeprazole stimulates growth of gastric mucosa but not of pancreas or intestines in hamster, guinea pig and chicken. Regul Pept 1988;23:105-15.
4. Ryberg B, Tielemans Y, Axelson J, Carlsson E, Håkansson R, Matton H, et al. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Gastroenterology 1990;99:935-42.
5. Bordi C, Costa A, Missale G. ECL cell proliferation and gastrin levels. Gastroenterology 1975;68:205-6.
6. Boren K, Renvall H, Liedberg G, Andersen BN. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986; 21:357-63.
7. Cattan D, Roucayrol A-M, Launay J-M, Callebert J, Charasz N, Nurit Y, et al. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology 1989;97:586-96.
8. Bordi C, Cocconi G, Togni R, Vezzadini P, Missale G. Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol 1974;98:274-9.
9. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type I multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 1990;14:503-13.
10. Borch K. Atrophic gastritis and carcinoid tumours. Ann Med 1989;21:291-7.
11. Solcia E, Fiocca R, Villani L, Gianatti A, Cornaggia M, Chiaravalli A, et al. Morphology and pathogenesis of endocrine hypeplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1991;26 Suppl 180:146-59.
12. Borch K, Renvall H, Liedborg G. Gastric endocrine cell hyperplasia and carcinoid tumours in pernicious anemia. Gastroenterology 1985;88:638-48.
13. Sjöblom S-M, Haapiainen R, Miettinen M, Järvinen H. Gastric carcinoid tumours and atrophic gastritis. Acta Chir Scand 1987; 153:37-43.
14. Winkler H, Fisher-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 1992;49: 497-528.
15. Hendy GN, Bevan S, Mattei M-G, Mouland AJ. Chromogranin A. Clin Invest Med 1995;18:47-65.
16. Stabile BE, Howard TJ, Passaro Jr E, O'Connor DT. Source of plasma chromogranin A elevation in gastrinoma patients. Arch Surg 1990;125:451-3.
17. Syversen U, Mignon M, Bonfils S, Kristensen A, Waldum HL. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol 1993;32:161-5.
18. Belaiche J, Delwaide J, Vivario M, Gast P, Louis E, Boniver J. Fundic argyrophil cell hyperplasia in atrophic gastritis: a search for a sensitive diagnostic method. Actda Gastroenterol Belg 1993;56:11-7.
19. Fahrenkamp AG, Wibbeke C, Winde G, Ofner D, Blocker W, Fisher-Colbrie R, et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch 1995;426: 361-7.
20. Borch K, Liedberg G. Prevalence and incidence of pernicious anemia. An evaluation for gastric screening. Scand J Gastroenterol 1984;19:154-60.
21. Borch K, Renvall H, Kullman E, Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases. Am J Sum Pathol 1987;11:435-44.
22. Jacobsen M, Clausen PP, Smidth S. The effect of fixation and trypsinization on the immunohistochemical demonstration of intracellular immunoglobulin in paraffin embedded material. Acta Pathol Microbiol Scand [G] 1980;88:369-76.
23. Stridsberg M, Hellman U, Wilander E, Lundqvist G, Hellsing K, Öberg K. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 1993;139:329-37.
24. Stridsberg M, Öberg K, Li Q, Engström U, Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995;144:49-59.
25. Price A. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209-22.
26. Anderson JM. Histometry. In: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. Edinburgh: Churchill Livingstone 1982:548-63.
27. Rehfeld JF, Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972;30:221-32.
28. Rehfeld JF. Sequence-specific radioimmunoassays for gastrin, cholecystokinin and somatostatin. Biomed Res 1980;1:73-8.
29. Waldum HL, Amestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gastroenterology 1996:110:A289.